# MYEF2

## Overview
MYEF2, or Myelin Expression Factor 2, is a gene that encodes a transcriptional repressor protein involved in the regulation of gene expression, particularly within hematopoietic and neural cells. The MYEF2 protein plays a critical role in maintaining the undifferentiated state of erythroid cells by forming complexes with transcription factors such as RUNX1 to repress specific hematopoietic genes (van2012A). Additionally, MYEF2 is implicated in the regulation of the myelin basic protein (MBP) gene, where it acts as a negative regulator during brain development, interacting with proteins like MEF-1/Pur α to modulate transcription (Muralidharan1997Evidence). Beyond its developmental roles, MYEF2 has clinical significance in conditions such as hepatocellular carcinoma, where its expression levels are associated with disease progression and prognosis (Zhang2023Expression).

## Function
MYEF2, or Myelin Expression Factor 2, is a transcriptional repressor that plays a significant role in the regulation of gene expression in hematopoietic cells, particularly in erythroid cells. It functions primarily in undifferentiated cells, where it forms a complex with the transcription factor RUNX1 to repress hematopoietic genes. This interaction is crucial for maintaining the undifferentiated state of these cells and is lost upon differentiation (van2012A). MYEF2 is known to bind DNA directly through its RNA recognition motifs, acting as a repressor of the mouse myelin basic protein gene (van2012A).

In the context of hematopoietic development, MYEF2 is involved in the suppression of genes such as Runx1, Cbfa2t3 (Eto2), and Gata1. Knock-down experiments in undifferentiated MEL cells have shown that reducing MYEF2 levels leads to increased expression of these genes, indicating its role in gene repression (van2012A). Additionally, MYEF2 knock-down in zebrafish results in defects in definitive hematopoiesis, highlighting its importance in hematopoietic development (van2012A). MYEF2 is active in the nucleus, where it influences cellular differentiation and neural function, contributing to the development and maintenance of the nervous system by modulating the transcription of genes necessary for myelin sheath formation.

## Clinical Significance
MYEF2 has been implicated in various diseases and conditions due to its altered expression levels and interactions. In hepatocellular carcinoma (HCC), MYEF2 expression is significantly upregulated in cancerous tissues compared to normal liver tissues. This upregulation is associated with poorer overall survival and disease-specific survival in HCC patients, making MYEF2 an independent risk factor for poor prognosis. High MYEF2 expression correlates with advanced tumor stages and poorly differentiated tumors, suggesting its role in cancer progression by enhancing the invasive and migratory capabilities of cancer cells (Zhang2023Expression).

MYEF2 is also involved in hematopoietic development. In erythroid cells, MYEF2 forms a complex with RUNX1, acting as a repressor of certain hematopoietic genes. Knockdown of MYEF2 in zebrafish results in defects in definitive hematopoiesis, indicating its crucial role in hematopoietic development (van2012A).

In the context of neurological functions, MYEF2 interacts with MEF-1/Pur α in the regulation of the myelin basic protein (MBP) gene. MYEF2 acts as a repressor, and its binding is inhibited by MEF-1, which promotes MBP transcription during myelination. This interaction is crucial for proper brain development and myelin formation (Muralidharan1997Evidence).

## Interactions
MYEF2 (myelin expression factor 2) is a transcriptional repressor that participates in several interactions with other proteins and nucleic acids. It is known to interact with the transcription factor RUNX1 in undifferentiated erythroid cells, forming a complex that represses hematopoietic genes. This interaction was confirmed through immunoprecipitation experiments, and knock-down studies of MYEF2 in undifferentiated MEL cells showed increased expression of genes like Runx1, indicating that MYEF2 acts as a repressor in this context (van2012A).

In the context of myelin basic protein (MBP) gene regulation, MYEF2 interacts with MEF-1/Pur α. MEF-1/Pur α can decrease the binding of MYEF2 to the MB1 sequence of the MBP promoter, suggesting a competitive interaction. This interaction is developmentally regulated, with MEF-1/Pur α acting as a positive regulator and MYEF2 as a negative regulator of MBP gene transcription during brain development. The presence of MEF-1/Pur α enhances the dimeric binding of MYEF2 to the MB1 sequence, indicating a complex interplay between these proteins in regulating MBP transcription (Muralidharan1997Evidence).


## References


[1. (van2012A) Boet van Riel, Tibor Pakozdi, Rutger Brouwer, Rui Monteiro, Kapil Tuladhar, Vedran Franke, Jan Christian Bryne, Ruud Jorna, Erik-Jan Rijkers, Wilfred van Ijcken, Charlotte Andrieu-Soler, Jeroen Demmers, Roger Patient, Eric Soler, Boris Lenhard, and Frank Grosveld. A novel complex, runx1-myef2, represses hematopoietic genes in erythroid cells. Molecular and Cellular Biology, 32(19):3814–3822, October 2012. URL: http://dx.doi.org/10.1128/mcb.05938-11, doi:10.1128/mcb.05938-11. This article has 32 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1128/mcb.05938-11)

[2. (Zhang2023Expression) Peng Zhang, Jiang-Hua Zhao, Lin Chen, Zhao-Lian Bian, Lin-Ling Ju, Hui-Xuan Wang, and Wei-Hua Cai. Expression and function of myelin expression factor 2 in hepatocellular carcinoma. BMC Gastroenterology, January 2023. URL: http://dx.doi.org/10.1186/s12876-023-02644-3, doi:10.1186/s12876-023-02644-3. This article has 2 citations and is from a peer-reviewed journal.](https://doi.org/10.1186/s12876-023-02644-3)

[3. (Muralidharan1997Evidence) Vandhana Muralidharan, Anna Tretiakova, Andrew Steplewski, Susan Haas, Shohreh Amini, Edward Johnson, and Kamel Khalili. Evidence for inhibition of myef-2 binding to mbp promoter by mef-1/pur α. Journal of Cellular Biochemistry, 66(4):524–531, September 1997. URL: http://dx.doi.org/10.1002/(SICI)1097-4644(19970915)66:4<524::AID-JCB11>3.0.CO;2-B, doi:10.1002/(sici)1097-4644(19970915)66:4<524::aid-jcb11>3.0.co;2-b. This article has 36 citations and is from a peer-reviewed journal.](https://doi.org/10.1002/(SICI)1097-4644(19970915)66:4)